Posterior laryngitis: a disease with different aetiologies affecting health-related quality of life: a prospective case-control study.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3846677)

Published in BMC Ear Nose Throat Disord on September 09, 2013

Authors

Hillevi Pendleton1, Marianne Ahlner-Elmqvist, Rolf Olsson, Ola Thorsson, Oskar Hammar, Magnus Jannert, Bodil Ohlsson

Author Affiliations

1: Department of Clinical Sciences, Division of Oto-Rhino-Laryngology, Skåne University Hospital, Malmö, Lund University, Lund, Sweden. Hillevi.Pendleton@med.lu.se.

Articles cited by this

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther (2003) 3.41

The validity and reliability of the reflux finding score (RFS). Laryngoscope (2001) 2.88

Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology (1997) 2.39

Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut (2009) 1.97

Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology (1986) 1.87

Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl (1996) 1.63

Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut (2012) 1.48

Gastroesophageal reflux/laryngopharyngeal reflux disease: a critical analysis of the literature. Eur Arch Otorhinolaryngol (2010) 1.47

Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg (2000) 1.46

Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol (1993) 1.31

Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol (2001) 1.29

Symptoms by age and sex. The population studies of men and women in Gothenburg, Sweden. Scand J Prim Health Care (1990) 1.29

Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope (2001) 1.27

Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology (2007) 1.22

A new pH catheter for laryngopharyngeal reflux: Normal values. Laryngoscope (2009) 1.19

Esophageal dysmotility and gastroesophageal reflux disease. J Gastrointest Surg (2001) 1.18

Anatomy and physiology of the gastroesophageal junction. Gastroenterol Clin North Am (1997) 1.15

Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Dig Dis Sci (2002) 1.13

Laryngopharyngeal reflux: More questions than answers. Cleve Clin J Med (2010) 1.12

Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). BMC Gastroenterol (2007) 1.10

Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. Aliment Pharmacol Ther (2011) 1.10

Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre. Neurogastroenterol Motil (2007) 1.09

The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol (2004) 1.04

A course of instruction for women with irritable bowel syndrome. Patient Educ Couns (2005) 1.00

Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Gut (2011) 0.99

Disturbed motilin and cholecystokinin release in the irritable bowel syndrome. Scand J Gastroenterol (1996) 0.98

Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin-releasing hormone in serum. Neurogastroenterol Motil (2011) 0.94

Acid reflux treatment for hoarseness. Cochrane Database Syst Rev (2006) 0.94

Impact of endoscopic sinus surgery on global health perception: an outcomes study. Otolaryngol Head Neck Surg (1998) 0.92

Quality of life in laryngopharyngeal reflux patients. Laryngoscope (2007) 0.91

The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope (2004) 0.89

Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux. Laryngoscope (2001) 0.88

Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol Suppl (2000) 0.87

Diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg (2006) 0.87

Gastroesophageal reflux disease is associated with enteric hormone abnormalities. Am J Surg (1994) 0.86

Release of motilin in man. Scand J Gastroenterol Suppl (1976) 0.84

Alterations of gut neuropeptides in gastroesophageal reflux disease are resolved after antireflux surgery. Am J Surg (2000) 0.81

The role of motilin and cisapride in the enteric nervous system of the lower esophageal sphincter in humans. Surg Today (1997) 0.80

Posterior laryngitis: a study of persisting symptoms and health-related quality of life. Eur Arch Otorhinolaryngol (2012) 0.79

Antibodies against gonadotropin-releasing hormone in patients with posterior laryngitis. Drug Target Insights (2013) 0.78

Motilin concentrations in relation to gastro intestinal dysmotility in diabetes mellitus. Eur J Intern Med (2009) 0.77

The frontiers of reflux disease. Dig Dis Sci (2006) 0.77

Pharyngeal reflux episodes at pH 5 in healthy volunteers. Scand J Gastroenterol (2006) 0.77

Pharyngeal and laryngeal symptoms and signs related to extraesophageal reflux in patients with heartburn in gastroenterology practice: a prospective study. Clin Otolaryngol (2005) 0.77

Articles by these authors

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol (2002) 3.72

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06

Outcome and prognostic markers in severe drug-induced liver disease. Hepatology (2005) 2.36

Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol (2004) 2.30

The natural history of small-duct primary sclerosing cholangitis. Gastroenterology (2008) 1.92

Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol (2002) 1.67

Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology (2003) 1.34

Computed tomography measurements of different dimensions of maxillary and frontal sinuses. BMC Med Imaging (2011) 1.20

Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope (2005) 1.20

Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol (2008) 1.19

Supraglottic swallow, effortful swallow, and chin tuck did not alter hypopharyngeal intrabolus pressure in patients with pharyngeal dysfunction. Dysphagia (2002) 1.15

Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1. J Med Chem (2002) 1.14

Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). BMC Gastroenterol (2007) 1.10

Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol (2006) 1.09

Dorsal agenesis of the pancreas - a rare cause of abdominal pain and insulin-dependent diabetes. Acta Radiol (2011) 1.07

Ulcerated small-intestine duplication cyst: an unusual source of GI bleeding revealed by wireless capsule endoscopy. Gastrointest Endosc (2006) 1.07

Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int (2007) 1.06

The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver Int (2006) 1.05

Hepatic findings in long-term clinical trials of ximelagatran. Drug Saf (2005) 1.05

Correlation between simultaneous scintigraphic and ultrasonographic measurement of gastric emptying in patients with type 1 diabetes mellitus. J Ultrasound Med (2003) 1.04

Which cancer patients die in nursing homes? Quality of life, medical and sociodemographic characteristics. Palliat Med (2003) 1.03

Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol (2005) 1.02

Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer (2013) 1.00

A course of instruction for women with irritable bowel syndrome. Patient Educ Couns (2005) 1.00

Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol (2003) 1.00

Health-related quality of life during the last three months of life in patients with advanced cancer. Support Care Cancer (2008) 1.00

Oxytocin and oxytocin-receptor mRNA expression in the human gastrointestinal tract: a polymerase chain reaction study. Regul Pept (2004) 0.98

Serious adverse liver reactions associated with herbal weight-loss supplements. J Hepatol (2007) 0.98

The Lactobacillus flora in vagina and rectum of fertile and postmenopausal healthy Swedish women. BMC Womens Health (2011) 0.97

Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Liver Transpl (2003) 0.97

A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology (2011) 0.96

Daily physical activity and its relation to aerobic fitness in children aged 8-11 years. Eur J Appl Physiol (2006) 0.96

Small bowel enteroclysis with magnetic resonance imaging and computed tomography in patients with failed and uncertain passage of a patency capsule. BMC Med Imaging (2012) 0.95

The nursing and medical students motivation to attain knowledge. Nurse Educ Today (2009) 0.94

Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol (2008) 0.94

Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract. Cell Tissue Res (2012) 0.93

Gender differences and determinants of aerobic fitness in children aged 8-11 years. Eur J Appl Physiol (2006) 0.92

Place of death: hospital-based advanced home care versus conventional care. A prospective study in palliative cancer care. Palliat Med (2004) 0.92

BMI and objectively measured body fat and body fat distribution in prepubertal children. Clin Physiol Funct Imaging (2007) 0.90

Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number. Pancreatology (2003) 0.89

Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response. Scand J Gastroenterol (2010) 0.87

Depletion of enteric gonadotropin-releasing hormone is found in a few patients suffering from severe gastrointestinal dysmotility. Scand J Gastroenterol (2012) 0.87

Auto-antibodies and their association with clinical findings in women diagnosed with microscopic colitis. PLoS One (2013) 0.87

Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study. Int J Cancer (2014) 0.87

Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol (2011) 0.86

Clinical characteristics and prognostic markers in disulfiram-induced liver injury. J Hepatol (2006) 0.86

Lifestyle, dietary factors, and antibody levels to oral bacteria in cancer-free participants of a European cohort study. Cancer Causes Control (2013) 0.86

Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia, and autonomic neuropathy with hypergastrinemia. BMC Gastroenterol (2009) 0.86

Retrospective study of long-term treatment with sodium picosulfate. Eur J Gastroenterol Hepatol (2004) 0.86

Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol (2005) 0.86

Gastrointestinal symptoms and psychological well-being in patients with microscopic colitis. Scand J Gastroenterol (2012) 0.86

Autonomic nervous dysfunction development in patients with primary Sjogren's syndrome: a follow-up study. Rheumatology (Oxford) (2010) 0.86

Body fat, abdominal fat and body fat distribution related to cardiovascular risk factors in prepubertal children. Acta Paediatr (2012) 0.85

Impaired gastric emptying in primary Sjogren's syndrome. J Rheumatol (2010) 0.85

Expression and distribution of GnRH, LH, and FSH and their receptors in gastrointestinal tract of man and rat. Regul Pept (2013) 0.85

In vitro studies and safety assessment of Doppler ultrasound as a diagnostic tool in rhinosinusitis. Ultrasound Med Biol (2010) 0.85

Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes. Scand J Gastroenterol (2009) 0.85

Health-related quality of life in patients with pharyngeal carcinoma: a five-year follow-up. Head Neck (2006) 0.85

Lack of physical activity in young children is related to higher composite risk factor score for cardiovascular disease. Acta Paediatr (2011) 0.85

Microscopic Colitis is Associated with Several Concomitant Diseases. Drug Target Insights (2013) 0.85

Dominant strictures in patients with primary sclerosing cholangitis-revisited. Am J Gastroenterol (2004) 0.84

High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis. Liver Int (2007) 0.84

Clinical learning environment, supervision and nurse teacher evaluation scale: psychometric evaluation of the Swedish version. J Adv Nurs (2010) 0.84

Impact of exercise intensity and duration on insulin sensitivity in women with T2D. Eur J Intern Med (2010) 0.84

Inflammation as a cause of functional bowel disorders. Scand J Gastroenterol (2005) 0.84

Quality of life in oral carcinoma: a 5-year prospective study. Head Neck (2008) 0.84

Anxiety in close relationships is higher and self-esteem lower in patients with irritable bowel syndrome compared to patients with inflammatory bowel disease. Eur J Intern Med (2012) 0.84

Aerobic fitness related to cardiovascular risk factors in young children. Eur J Pediatr (2011) 0.84

Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy. Rev Diabet Stud (2011) 0.84

Porphyria cutanea tarda in a Swedish population: risk factors and complications. Acta Derm Venereol (2005) 0.84

Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization. BMC Pregnancy Childbirth (2013) 0.83

Expression of Luteinizing Hormone Receptor in the Gastrointestinal Tract in Patients with and without Dysmotility. Drug Target Insights (2012) 0.83

Psychological well-being and symptoms in women with chronic constipation treated with sodium picosulphate. Gastroenterol Nurs (2005) 0.83

Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis. J Hepatol (2009) 0.83

Evaluation of gastric acid secretion at endoscopy with a modified Congo red test. Gastrointest Endosc (2002) 0.83

Severe gastrointestinal dysmotility developed after treatment with gonadotropin-releasing hormone analogs. Scand J Gastroenterol (2015) 0.83

Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment. Anticancer Res (2003) 0.82

Health-related quality of life (HRQOL) in family members of cancer victims: results from a longitudinal intervention study in Norway and Sweden. Palliat Med (2004) 0.82

Further validation of the visual analogue scale for irritable bowel syndrome after use in clinical practice. Gastroenterol Nurs (2013) 0.82

Sympathetic nerve dysfunction is common in patients with chronic intestinal pseudo-obstruction. J Clin Gastroenterol (2008) 0.82

Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man. J Clin Endocrinol Metab (2003) 0.82

The expression of retinoic acid receptors and the effects in vitro by retinoids in human pancreatic cancer cell lines. Pancreas (2002) 0.82

Women with irritable bowel syndrome and their perception of a good quality of life. Gastroenterol Nurs (2007) 0.82

Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study. Am J Clin Nutr (2013) 0.82

Characteristics and quality of life of patients who choose home care at the end of life. J Pain Symptom Manage (2008) 0.81

Relation between cycling exercise capacity, fiber-type composition, and lower extremity muscle strength and muscle endurance. J Strength Cond Res (2011) 0.81

Mucosa-associated bacteria in two middle-aged women diagnosed with collagenous colitis. World J Gastroenterol (2012) 0.81

Porphyria cutanea tarda: effects and risk factors for hepatotoxicity from high-dose chloroquine treatment. Acta Derm Venereol (2007) 0.81

Wernicke's encephalopathy presenting with severe dysphagia: a case report. Alcohol Alcohol (2002) 0.81

Feasibility of measuring acoustic streaming for improved diagnosis of rhinosinusitis. Ultrasound Med Biol (2007) 0.80

Diarrhoea is not the only symptom that needs to be treated in patients with microscopic colitis. Eur J Intern Med (2013) 0.80